Smad7 mediates transforming growth factor-β-induced apoptosis in mesangial cells

Kidney International

Volumn 62, Issue 4, 2002, Pages 1178-1186

  Okado, Tomokazu ^a   Terada, Yoshio ^a   Tanaka, Hiroyuki ^a   Inoshita, Seiji ^a   Nakao, Atsuhito ^a   Sasaki, Sei ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Adenoviral vector; Caspase; Cell death; Glomerulus; Nuclear factor kappa B; Sclerosis; Signal transduction; TGF

Indexed keywords

ADENOVIRUS VECTOR; ANTISENSE OLIGONUCLEOTIDE; CASPASE 3; DNA; DNA FRAGMENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; SMAD PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; ELECTROPORATION; ENZYME ACTIVATION; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; MALE; MESANGIUM CELL; NONHUMAN; NUCLEOSOME; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION;

EID: 0036380988     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00583.x     Document Type: Article

References (47)

1. ABBOUD HE: Growth factors in glomerulonephritis. Kidney Int 43:252-267, 1993
2. FLOEGE J, ENG E, YOUNG BA, et al: Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo. Kidney Int 43(Suppl 39):S47-S54, 1993
3. HARRISON DJ: Cell death in the diseased glomerulus. Histopathology 12:679-683, 1988
4. BAKER AJ, MOONEY A, HUGHES J, et al: Mesangial cell apoptosis: The major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest 94:2105-2116, 1994
5. SHIMIZU A, KITAMURA H, MASUDA Y, et al: Apoptosis in the repair process of experimental proliferative glomerulonephritis. Kidney Int 47:114-121, 1995
6. SUGIYAMA H, KASHIHARA N, MAKINO H, et al: Apoptosis in glomerular sclerosis. Kidney Int 49:103-111, 1996
7. HELDIN CH, MIYAZONO K,TEN DIJKE P, et al: TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390:465-471, 1997
8. MASSAGUE J: TGF-beta signal transduction. Annu Rev Biochem 67:753-791, 1998
9. MACKAY K, STRIKER LJ, STAUFFER JW, et al: Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest 83:1160-1167, 1989
10. KLAHR S, SCHREINER G, ICHIKAWA I: The progression of renal disease. N Engl J Med 318:1657-1666, 1988
11. BORDER WA, OKUDA S, LANGUINO LR, et al: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta1. Nature 346:371-374, 1990
12. PATEL P, VARGHESE E, DING G, et al: Transforming growth factor beta induces mesangial cell apoptosis through NO- and p53-dependent and -independent pathways. J Invest Med 48:403-410, 2000
13. MIYAZONO K: TGF-beta signaling by Smad proteins. Cytokine Growth Factor Rev 11:15-22, 2000
14. PATIL S, WILDEY GM, BROWN TL, et al: Smad7 is induced by CD40 and protects WEHI231 B-lymphocytes from transforming growth factor-beta-induced growth inhibition and apoptosis. J Biol Chem 275:38363-38370, 2000
15. YAMAMURA Y, HUA X, BERGELSON S, et al: Critical role of Smads and AP-1 complex in transforming growth factor-beta-dependent apoptosis. J Biol Chem 275:36295-36302, 2000
16. LANDSTROM M, HELDIN NE, BU S, et al: Smad7 mediates apoptosis induced by transforming growth factor beta in prostatic carcinoma cells. Curr Biol 10:535-538, 2000
17. LALLEMAND F, MAZARS A, PRUNIER C, et al: Smad7 inhibits the survival nuclear factor kappaB and potentiates apoptosis in epithelial cells. Oncogene 20:879-884, 2001
18. SCHIFFER M, BITZER M, ROBERTS IS, et al: Apoptosis in podocytes induced by TGF-beta and Smad7. J Clin Invest 108:807-816, 2001
19. SCHIFFER M, VON GERSDORFF G, BITZER M, et al: Smad proteins and transforming growth factor-beta signaling. Kidney Int 58(Suppl 77):S45-S52, 2000
20. BITZER M, VON GERSDORFF G, LIANG D, et al: A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappaB/RelA. Genes Dev 14:187-197, 2000
21. NAGARAJAN RP, ZHANG J, LI W, et al: Regulation of Smad7 promoter by direct association with Smad3 and Smad4. J Biol Chem 274:33412-33418, 1999
22. NAKAO A, FUJII M, MATSUMURA R, et al: Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest 104:5-11, 1999
23. TERADA Y, YAMADA T, NAKASHIMA O, et al: Overexpression of cell cycle inhibitors (p16INK4 and p21Cip1) and cyclin D1 using adenovirus vectors regulates proliferation of rat mesangial cells. J Am Soc Nephrol 8:51-60, 1997
24. INOSHITA S, TERADA Y, NAKASHIMA O, et al: Roles of E2F1 in mesangial cell proliferation in vitro. Kidney Int 56:2085-2095, 1999
25. OWADA A, TOMITA K, TERADA Y, et al: Endothelin (ET)-3 stimulates cyclic guanosine 3′,5′-monophosphate production via ETB receptor by producing nitric oxide in isolated rat glomerulus, and in cultured rat mesangial cells. J Clin Invest 93:556-563, 1994
26. TERADA Y, INOSHITA S, HANADA S, et al: Hyperosmolality activates Akt and regulates apoptosis in renal tubular cells. Kidney Int 60:553-567, 2001
27. NAKASHIMA O, TERADA Y, INOSHITA S, et al: Inducible nitric oxide synthase can be induced in the absence of active nuclear factor-kappaB in rat mesangial cells: involvement of the Janus kinase 2 signaling pathway. J Am Soc Nephrol 10:721-729, 1999
28. NAKASHIMA O, TERADA Y, HANADA S, et al: Activated STAT1 suppresses proliferation of cultured rat mesangial cells. Kidney Int 57:2249-2257, 2000
29. TERADA Y, TOMITA K, HOMMA MK, et al: Sequential activation of Raf-1 kinase, mitogen-activated protein (MAP) kinase kinase, MAP kinase, and S6 kinase by hyperosmolality in renal cells. J Biol Chem 269:31296-31301, 1994
30. TERADA Y, NAKASHIMA O, INOSHITA S, et al: TGF-beta-activating kinase-1 inhibits cell cycle and expression of cyclin D1 and A in LLC-PK1 cells. Kidney Int 56:1378-1390, 1999
31. HAY E, LEMONNIER J, FROMIGUE O, et al: Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway. J Bio Chem 276:29028-29036, 2001
32. DANIEL C, DUFFIELD J, BRUNNER T, et al: Matrix metalloproteinase inhibitors cause cell cycle arrest and apoptosis in glomerular mesangial cells. J Pharmacol Exp Ther 297:57-68, 2001
33. SUGIYAMA H, SAVILL JS, KITAMURA M, et al: Selective sensitization to tumor necrosis factor-alpha-induced apoptosis by blockade of NF-kappaB in primary glomerular mesangial cells. J Biol Chem 274:19532-19537, 1999
34. IGNOTZ RA, MASSAGUE J: Cell adhesion protein receptors as targets for transforming growth factor-beta action. Cell 51:189-197, 1987
35. ISAKA Y, FUJIWARA Y, UEDA N, et al: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet derived growth factor gene into the rat kidney. J Clin Invest 92:2597-2601, 1993
36. COIMBRA T, WIGGINS R, NOH JW, et al: Transforming growth factor-beta production in anti-glomerular basement membrane disease in the rabbit. Am J Pathol 138:223-234, 1991
37. BARNES PJ, KARIN M: Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071, 1997
38. WU M, LEE H, BELLAS RE, et al: Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells. EMBO J 15:4682-4690, 1996
39. WANG CY, MAYO MW, BALDWIN AS JR: TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-kappaB. Science 274:784-787, 1996
40. VAN ANTWERP DJ, MARTIN SJ, KAFRI T, et al: Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274:787-789, 1996
41. ISHISAKI A, YAMATO K, HASHIMOTO S, et al: Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells. J Biol Chem 274:13637-13642, 1999
42. ISHISAKI A, YAMATO K, NAKAO A, et al: Smad7 is an activin-inducible inhibitor of activin-induced growth arrest and apoptosis in mouse B cells. J Biol Chem 273:24293-24296, 1998
43. BARISONI L, MOKRZYCKI M, SABLAY L, et al: Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies. Kidney Int 58:137-143, 2000
44. SHANKLAND SJ, EITNER F, HUDKINS KL, et al: Differential expression of cyclin-dependent kinase inhibitors in human glomerular disease: Role in podocyte proliferation and maturation. Kidney Int 58:674-683, 2000
45. NAGATA M, NAKAYAMA K, TERADA Y, et al: Cell cycle regulation and differentiation in the human podocyte lineage. Am J Pathol 153:1511-1520, 1998
46. STEFFES MW, SCHMIDT D, MCCRERY R, et al: Glomerular cell number in normal subjects and type 1 diabetic patients. Kidney Int 59:2104-2113, 2001
47. JOLES JA, KUNTER U, JANSSEN U, et al: Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats. J Am Soc Nephrol 11:669-683, 2000